HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe.

Abstract
AZD1152, an Aurora kinase inhibitor with selectivity for Aurora B kinase, can enhance the effect of ionizing radiation (IR). The aim of this study was to evaluate and to mechanistically explore scheduling effects of AZD1152 on tumor responses to IR, in three different settings: neoadjuvant (AZD1152 before IR), adjuvant (IR before AZD1152), or concomitant treatments (AZD1152 plus one single IR dose). A more pronounced tumor growth delay was observed in the neoadjuvant and adjuvant schedules as compared to the concomitant schedule. However, AZD1152 enhanced the efficacy of IR when concomitant IR was fractionated over several days. Histopathological examination revealed that AZD1152 + IR induced polyploidy, multinucleation and micronuclei in vivo. Time-lapse videomicroscopy confirmed that cell death induced by AZD1152 + IR was preceded by multinucleation and the formation of micronuclei, which both are hallmarks of mitotic catastrophe. Caspase inhibition or removal of the pro-apoptotic protein Bax did not ameliorate the long-term cell survival of AZD1152-treated cancer cells. In contrast, a chemical inhibitor of CHK1, Chir124, sensitized cancer cells to the lethal effect of AZD1152. Altogether, these data support the contention that AZD1152 mediates radiosensitization in vivo by enhancing mitotic catastrophe, which can be used as a biomarker of treatment efficacy.
AuthorsYungan Tao, Céline Leteur, Julien Calderaro, Fiona Girdler, Ping Zhang, Valérie Frascogna, Mariana Varna, Paule Opolon, Maria Castedo, Jean Bourhis, Guido Kroemer, Eric Deutsch
JournalCell cycle (Georgetown, Tex.) (Cell Cycle) Vol. 8 Issue 19 Pg. 3172-81 (Oct 01 2009) ISSN: 1551-4005 [Electronic] United States
PMID19755861 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-((3-((4-((5-(2-((3-fluorophenyl)amino)-2-oxoethyl)-1H-pyrazol-3-yl)amino)quinazolin-7-yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphate
  • Organophosphates
  • Protein Kinase Inhibitors
  • Quinazolines
  • AURKB protein, human
  • Aurkb protein, mouse
  • Aurora Kinase B
  • Aurora Kinases
  • Protein Serine-Threonine Kinases
  • Caspases
Topics
  • Animals
  • Apoptosis (drug effects)
  • Aurora Kinase B
  • Aurora Kinases
  • Caspases (metabolism)
  • Cell Line, Tumor
  • HCT116 Cells
  • Humans
  • Mice
  • Mice, Nude
  • Mitosis
  • Organophosphates (pharmacology)
  • Protein Kinase Inhibitors (pharmacology)
  • Protein Serine-Threonine Kinases (antagonists & inhibitors, metabolism)
  • Quinazolines (pharmacology)
  • Radiation, Ionizing
  • Transplantation, Heterologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: